| Name (Synonyms) | Correlation |
|---|
| Name (Synonyms) | Correlation | |
|---|---|---|
| D003141 | Communicable Diseases NIH | 0.08 |
| D007239 | Infection NIH | 0.05 |
| Name (Synonyms) | Correlation |
|---|
There is one clinical trial.
Prospective assay for SARS-CoV-2 antibody detection indirectly by immunofluorescence: SARS-CoV2 IIF method
Description: Sensitivity of the method by SARS-CoV2 ELISA compared
Measure: Sensitivity of the method by SARS-CoV2 ELISA compared Time: 8 monthsDescription: Detectability of the antibodies IgA type against SARS-CoV2 virus in the early stages of the disease.
Measure: Detectability of the antibodies IgA type against SARS-CoV2 virus Time: 8 months